Get A Free Quote / Need Help?
A Fortune 500 pharmaceutical company was experiencing increased complexity associated with releasing clinical batches to global locations.
Global biologic enterprise drug manufacturer determined that human error was a major contributing factor to considerable manufacturing deviations.
Seattle-based biotech with two newly commissed plants to be built on the East and West coasts needed supply chain streamlining.
Pharmaceutical manufacturing site sought 50% reduction in Cost per Gram.
Leading biotech manufacturer requested help to meet three key business drivers.
A large pharmaceutical enterprise was reorganizing due to a separation event and required a structure to manage capital projects in the regulatory function.
A global biotechnology client initiated a $9B acquisition, with a goal to fully integrate and ensure operation and compliance of quality systems.
